Ilya Gipp MD, PhD’s Post

Colorectal cancer is the third most common form of cancer diagnosed in the United States. Buffalo Hospital is the first location in the Allina Health system to use an artificial intelligence-based tool to screen for colorectal cancer. Called GI Genius, it is designed to help with the detection of colorectal polyps, often the precursor to colorectal cancer. This tool helps the provider detect flat polyps faster and in hard-to-view areas. This is another example of Allina Health being a leader in care innovations that leverage technologies, like artificial intelligence. Read more about this at the link in the comments. #HealthInnovation #Colonoscopy #ArtificialIntelligence Medtronic

Prostate Cancer Awareness Video by Dr. Rakesh Sharma • Discusses the importance of regular screenings for early detection. • Highlights early warning signs like urinary difficulties, pain, or discomfort. • Discusses cutting-edge treatments like minimally invasive surgeries, radiation therapy, and immunotherapy advancements. • Encourages awareness and early action to protect health and future. #ProstateCancerAwareness #MensHealth #EarlyDetection #CancerScreening #UroOncology #ProstateHealth #CancerPrevention #HealthEducation #FightCancer #Immunotherapy #CancerResearch #CancerAwarness #Cancer #Oncology Dr. Rakesh Sharma Basavatarakam Cancer Hospital and Research Institute

"AI as an Always-available Oncologist: A Vision for AI-optimized Cancer Therapy Based on Real-time Adaptive Dosing at the Patient Level" Authors: Gabriel Kalweit, Luis García Valiña, Ignacio Mastroleo, Anusha Klett, Joschka Boedecker, Roland Mertelsmann, Maria Kalweit. 🔬 Exciting potential ahead: AI-powered cancer therapy! Learn about the vision for personalized treatment & overcoming challenges in this article: https://bit.ly/3Ty2QOK #AI #CancerTherapy #HealthTech

As the most common #cancer (after skin cancer) and second leading cancer cause of death in American men, #ProstateCancer is among the largest #health concerns for #men today. #RadiationTherapy is a highly effective and minimally invasive #treatment option for many men with prostate cancer, offering low side effect risks. Learn as Rutgers Cancer Institute, RWJBarnabas Health and Cooperman Barnabas Medical Center experts explore the latest in #radiation therapy for prostate cancer. https://lnkd.in/gq-iknsv #RadOnc

On World Lung Cancer Day, Dr Suneel Kaushik, Consultant - Surgical Oncology, American Oncology Institute, Hyderabad discusses important topics related to lung cancer. He explains how the disease impacts breathing and why a simple blood test may not always be enough for detection. Learn about the increased lung cancer risk from secondhand smoke and the surprising differences in how it affects men and women. Watch the video to stay informed and make informed health choices! #WorldLungCancerDay #AOIHyderabad #LungCancerAwareness #AmericanOncologyInstitute #AOICancerCare #WeJourneyWithyou

Important steps towards further personalizing radiation therapy, considering late toxicity as an important component of outcome.

Dr. Rakesh Sharma Prostate Cancer Awareness – Protect Your Future! Prostate cancer is one of the most common cancers affecting men, but early detection can make all the difference! In this informative video, Dr. Rakesh Sharma, our Senior Consultant Uro Oncologist, discusses the importance of regular screenings, early warning signs, and cutting-edge treatments that can save lives. Don’t wait—awareness is the first step towards prevention. Share this video to help spread life-saving information! #ProstateCancerAwareness #MensHealthMatters #EarlyDetectionSavesLives #BasavatarakamCancerHospital #CancerPrevention #urooncology

Think testosterone therapy is off-limits after a prostate cancer diagnosis? Think again. Research shows prostate cancer only relies on testosterone up to a certain point—levels above 250 ng/dL don’t increase risk, and low testosterone might even worsen outcomes. Studies also suggest testosterone therapy doesn’t cause cancer recurrence, even in advanced cases, and may reduce the risk of aggressive cancer. While the American Urological Association supports testosterone therapy for low-risk cases, outdated myths still hold many doctors back. If you’re a prostate cancer survivor with low testosterone, talk to your doctor—it might be time to reconsider. #ProstateCancer #TestosteroneTherapy #MedicalMyths

A meta-analysis of 5,504 patients revealed that pretreatment of [18F]FDG-PET metrics can predict outcomes in esophageal cancer. Higher SUVmax was significantly associated with poor progression-free survival (PFS) and recurrence-free survival (RFS)/disease-free survival (DFS), while SUVmean and metabolically active tumor volume are tied to worse OS. (Mingxing Huang et al.) #EuropeanRadiology 🔗 https://buff.ly/49Hac8X

A systematic review reveals distinct characteristics of early-onset colorectal cancer. It's less likely to involve KRAS, BRAF, and APC mutations but shows higher rates of TP53 and PTEN mutations. Additionally, it's linked to more aggressive histological features like high-grade and signet ring cell histologies. These findings underscore the importance of developing specialized treatment approaches for this younger patient group, potentially leading to better prognostic outcomes. Let’s discuss how these insights can transform care for early-onset CRC patients. #ColorectalCancer #CancerResearch #MedicalInnovation 🧬